| Suspended | Cleansing Device for the Treatment of Scalp and Hair Conditions NCT05319444 | University of Minnesota | N/A |
| Not Yet Recruiting | ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patie NCT07404033 | Sinomune Pharmaceutical Co., Ltd | Phase 1 |
| Active Not Recruiting | A Clinical Study to Assess the Safety and Effectiveness of Scalp Cream for Symptom Relief and Microbiome Balan NCT07063615 | NovoBliss Research Pvt Ltd | N/A |
| Completed | Phenotypic and Functional Profile of Peripheral Blood Lymphomonocytes in Seborrheic Dermatitis. NCT07297446 | San Gallicano Dermatological Institute IRCCS | — |
| Completed | Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin NCT07428915 | AI Labs Group S.L | — |
| Terminated | PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea NCT06013371 | Icahn School of Medicine at Mount Sinai | Phase 2 |
| Recruiting | The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis NCT05942248 | Integrative Skin Science and Research | N/A |
| Completed | Ruxolitinib in Seborrheic Dermatitis NCT05787860 | Icahn School of Medicine at Mount Sinai | Phase 2 |
| Completed | Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp NCT05105139 | Laboratorios Silanes S.A. de C.V. | — |
| Completed | Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STR NCT04973228 | Arcutis Biotherapeutics, Inc. | Phase 3 |
| Completed | Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis NCT04445987 | Arcutis Biotherapeutics, Inc. | Phase 2 |
| Completed | Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis NCT04472546 | Pierre Fabre Dermo Cosmetique | N/A |
| Completed | Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis NCT04091646 | Arcutis Biotherapeutics, Inc. | Phase 2 |
| Completed | Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis Patients NCT03807453 | Istanbul Medeniyet University | — |
| Unknown | Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis NCT03688971 | Maruho Co., Ltd. | Phase 2 |
| Completed | A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With NCT03567980 | University of Alabama at Birmingham | Phase 4 |
| Completed | Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic Dermatitis NCT03114111 | University of California, Davis | EARLY_Phase 1 |
| Completed | Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis NCT02656368 | Kamedis Ltd. | N/A |
| Completed | A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis NCT02749383 | Amorepacific Corporation | Phase 2 |
| Completed | Neurobiology of the Scalp in Seborrheic Dermatitis NCT02349854 | Boston University | — |
| Completed | Safety and Efficacy Study in Subjects With Seborrheic Dermatitis NCT01703793 | Medicis Global Service Corporation | Phase 2 |
| Unknown | Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea NCT01139749 | Federal University of São Paulo | Phase 4 |
| Terminated | Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation NCT01315951 | Ascension Health | N/A |
| Completed | Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis NCT01591070 | Pusan National University Hospital | Phase 4 |
| Completed | Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo NCT01203189 | St. Louis University | N/A |
| Unknown | Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic NCT01024374 | Allergisa Pesquisa Dermato-Cosmetica LTDA | — |
| Completed | The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage NCT00991198 | Aria Aesthetics Inc. | Phase 2 |
| Unknown | Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients NCT00767546 | Rabin Medical Center | Phase 1 |
| Completed | HairMax LaserComb Open Label Study to Treat Seborrheic Dermatitis NCT00830908 | Lexington International, LLC | N/A |
| Completed | Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic Dermatitis NCT00565279 | Astion Pharma A/S | Phase 3 |
| Completed | A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis NCT00403559 | Dermatology Specialists Research | Phase 2 |